Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery

NCT01612351 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer
Squamous Cell Carcinoma of the Head and Neck

Interventions

DRUG: Carboplatin
DRUG: Paclitaxel
DRUG: Lapatinib
DRUG: Cisplatin
DRUG: Cisplatin
RADIATION: Ipsilateral Radiation
RADIATION: Bilateral Radiation
PROCEDURE: Transoral Surgery

Sponsor

UNC Lineberger Comprehensive Cancer Center

Collaborators

[object Object]